nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Topotecan—peripheral nervous system neoplasm	0.175	0.315	CbGbCtD
Clofarabine—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.121	0.218	CbGbCtD
Clofarabine—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0748	0.134	CbGbCtD
Clofarabine—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0698	0.125	CbGbCtD
Clofarabine—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0686	0.123	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0468	0.084	CbGbCtD
Clofarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.00995	0.13	CbGpPWpGaD
Clofarabine—RRM2—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.00819	0.107	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00346	0.0453	CbGpPWpGaD
Clofarabine—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00343	0.045	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00308	0.0403	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00285	0.0373	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00266	0.0349	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00253	0.0332	CbGpPWpGaD
Clofarabine—RRM2—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.00247	0.398	CbGdCrCtD
Clofarabine—DCK—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00237	0.031	CbGpPWpGaD
Clofarabine—POLA1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00233	0.376	CbGdCrCtD
Clofarabine—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.002	0.0262	CbGpPWpGaD
Clofarabine—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.00197	0.0258	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00195	0.0255	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.0015	0.0197	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000938	0.0123	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000847	0.0111	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000802	0.0105	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000764	0.01	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000737	0.00965	CbGpPWpGaD
Clofarabine—DCK—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000729	0.118	CbGdCrCtD
Clofarabine—DCK—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.109	CbGdCrCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000671	0.0088	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000661	0.00866	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000629	0.00824	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000615	0.00806	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000605	0.00792	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000597	0.00782	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000553	0.00724	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000552	0.00723	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000518	0.00678	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000492	0.00644	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00046	0.00602	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.00045	0.00589	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000436	0.00571	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00043	0.00564	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000426	0.00559	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000415	0.00544	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000403	0.00528	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000385	0.00504	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000378	0.00496	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.00037	0.00485	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000369	0.00484	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000346	0.00454	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000346	0.00454	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000341	0.00446	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000338	0.00443	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000332	0.00435	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000328	0.0043	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00031	0.00407	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000309	0.00405	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000307	0.00402	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000304	0.00399	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000294	0.00385	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GNS—peripheral nervous system neoplasm	0.000292	0.00382	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000292	0.00382	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000284	0.00372	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NME1—peripheral nervous system neoplasm	0.00028	0.00366	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—COX2—peripheral nervous system neoplasm	0.000269	0.00353	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000263	0.00345	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000263	0.00344	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000261	0.00342	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000253	0.00332	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000247	0.00324	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GNS—peripheral nervous system neoplasm	0.00024	0.00315	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.00024	0.00314	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NME1—peripheral nervous system neoplasm	0.00023	0.00302	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000225	0.00294	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GNS—peripheral nervous system neoplasm	0.000224	0.00294	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—COX2—peripheral nervous system neoplasm	0.000222	0.0029	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	0.000219	0.00287	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NME1—peripheral nervous system neoplasm	0.000215	0.00282	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000213	0.00279	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000212	0.00277	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000208	0.00273	CbGpPWpGaD
Clofarabine—DCK—Metabolism—COX2—peripheral nervous system neoplasm	0.000207	0.00271	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000201	0.00263	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000197	0.00258	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—peripheral nervous system neoplasm	0.000195	0.00255	CbGpPWpGaD
Clofarabine—POLA1—S Phase—MYC—peripheral nervous system neoplasm	0.000192	0.00252	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000191	0.0025	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.00019	0.00249	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000184	0.00241	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.00018	0.00235	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000178	0.00234	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000177	0.00232	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000177	0.00231	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000173	0.00227	CbGpPWpGaD
Clofarabine—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000475	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000475	CcSEcCtD
Clofarabine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000475	CcSEcCtD
Clofarabine—Rash—Melphalan—peripheral nervous system neoplasm	0.000171	0.000473	CcSEcCtD
Clofarabine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000171	0.000473	CcSEcCtD
Clofarabine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000471	CcSEcCtD
Clofarabine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000471	CcSEcCtD
Clofarabine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000469	CcSEcCtD
Clofarabine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000468	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000168	0.000466	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000462	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000462	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000166	0.00218	CbGpPWpGaD
Clofarabine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000459	CcSEcCtD
Clofarabine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000165	0.000458	CcSEcCtD
Clofarabine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.000456	CcSEcCtD
Clofarabine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.000456	CcSEcCtD
Clofarabine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000164	0.000456	CcSEcCtD
Clofarabine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000164	0.000454	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000453	CcSEcCtD
Clofarabine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000163	0.000452	CcSEcCtD
Clofarabine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000163	0.000452	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000448	CcSEcCtD
Clofarabine—Infection—Etoposide—peripheral nervous system neoplasm	0.000161	0.000447	CcSEcCtD
Clofarabine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000161	0.000446	CcSEcCtD
Clofarabine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000161	0.000446	CcSEcCtD
Clofarabine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000445	CcSEcCtD
Clofarabine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000444	CcSEcCtD
Clofarabine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000442	CcSEcCtD
Clofarabine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000441	CcSEcCtD
Clofarabine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000159	0.000441	CcSEcCtD
Clofarabine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000158	0.000439	CcSEcCtD
Clofarabine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000158	0.000439	CcSEcCtD
Clofarabine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000158	0.000439	CcSEcCtD
Clofarabine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000438	CcSEcCtD
Clofarabine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000158	0.000437	CcSEcCtD
Clofarabine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000435	CcSEcCtD
Clofarabine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000157	0.000435	CcSEcCtD
Clofarabine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000435	CcSEcCtD
Clofarabine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000434	CcSEcCtD
Clofarabine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000155	0.000429	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000428	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000428	CcSEcCtD
Clofarabine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000154	0.000427	CcSEcCtD
Clofarabine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000154	0.000425	CcSEcCtD
Clofarabine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000425	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000153	0.000424	CcSEcCtD
Clofarabine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000421	CcSEcCtD
Clofarabine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000152	0.000421	CcSEcCtD
Clofarabine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000152	0.00042	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000419	CcSEcCtD
Clofarabine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000415	CcSEcCtD
Clofarabine—RRM1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000149	0.00196	CbGpPWpGaD
Clofarabine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.000414	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000412	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00041	CcSEcCtD
Clofarabine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000148	0.000409	CcSEcCtD
Clofarabine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.000408	CcSEcCtD
Clofarabine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000405	CcSEcCtD
Clofarabine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000146	0.000404	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000146	0.00191	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000145	0.00191	CbGpPWpGaD
Clofarabine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000402	CcSEcCtD
Clofarabine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000401	CcSEcCtD
Clofarabine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000145	0.000401	CcSEcCtD
Clofarabine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000144	0.0004	CcSEcCtD
Clofarabine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000144	0.000399	CcSEcCtD
Clofarabine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000398	CcSEcCtD
Clofarabine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000396	CcSEcCtD
Clofarabine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000396	CcSEcCtD
Clofarabine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.000395	CcSEcCtD
Clofarabine—RRM1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000142	0.00187	CbGpPWpGaD
Clofarabine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000395	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000392	CcSEcCtD
Clofarabine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000141	0.000392	CcSEcCtD
Clofarabine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000141	0.000391	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.000141	0.00185	CbGpPWpGaD
Clofarabine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00039	CcSEcCtD
Clofarabine—RRM1—Metabolism—TH—peripheral nervous system neoplasm	0.00014	0.00184	CbGpPWpGaD
Clofarabine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000389	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00014	0.000389	CcSEcCtD
Clofarabine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000388	CcSEcCtD
Clofarabine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00014	0.000388	CcSEcCtD
Clofarabine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000388	CcSEcCtD
Clofarabine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000386	CcSEcCtD
Clofarabine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000386	CcSEcCtD
Clofarabine—Pain—Etoposide—peripheral nervous system neoplasm	0.000139	0.000385	CcSEcCtD
Clofarabine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000384	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000382	CcSEcCtD
Clofarabine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000381	CcSEcCtD
Clofarabine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000137	0.00038	CcSEcCtD
Clofarabine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000377	CcSEcCtD
Clofarabine—DCK—Metabolism—ENO2—peripheral nervous system neoplasm	0.000136	0.00178	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000135	0.00177	CbGpPWpGaD
Clofarabine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000374	CcSEcCtD
Clofarabine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000373	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000371	CcSEcCtD
Clofarabine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000371	CcSEcCtD
Clofarabine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000134	0.000371	CcSEcCtD
Clofarabine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000133	0.000369	CcSEcCtD
Clofarabine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000368	CcSEcCtD
Clofarabine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000133	0.000368	CcSEcCtD
Clofarabine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000133	0.000367	CcSEcCtD
Clofarabine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.000367	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000366	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000366	CcSEcCtD
Clofarabine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000364	CcSEcCtD
Clofarabine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000363	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000363	CcSEcCtD
Clofarabine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000362	CcSEcCtD
Clofarabine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.000361	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.00013	0.00171	CbGpPWpGaD
Clofarabine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00036	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000359	CcSEcCtD
Clofarabine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000357	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000357	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000357	CcSEcCtD
Clofarabine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000128	0.000356	CcSEcCtD
Clofarabine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000128	0.000356	CcSEcCtD
Clofarabine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000355	CcSEcCtD
Clofarabine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000127	0.000353	CcSEcCtD
Clofarabine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000352	CcSEcCtD
Clofarabine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000351	CcSEcCtD
Clofarabine—Rash—Vincristine—peripheral nervous system neoplasm	0.000126	0.00035	CcSEcCtD
Clofarabine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000126	0.00035	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00035	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000126	0.00165	CbGpPWpGaD
Clofarabine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000349	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000349	CcSEcCtD
Clofarabine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000348	CcSEcCtD
Clofarabine—Headache—Vincristine—peripheral nervous system neoplasm	0.000126	0.000348	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000346	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000345	CcSEcCtD
Clofarabine—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000124	0.00163	CbGpPWpGaD
Clofarabine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000343	CcSEcCtD
Clofarabine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000342	CcSEcCtD
Clofarabine—RRM2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000123	0.00161	CbGpPWpGaD
Clofarabine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000336	CcSEcCtD
Clofarabine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000336	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.00012	0.00157	CbGpPWpGaD
Clofarabine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00012	0.000332	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00033	CcSEcCtD
Clofarabine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000119	0.00033	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00033	CcSEcCtD
Clofarabine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00033	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000329	CcSEcCtD
Clofarabine—RRM2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000117	0.00154	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000324	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000324	CcSEcCtD
Clofarabine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000117	0.000323	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000323	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000322	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000322	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000321	CcSEcCtD
Clofarabine—RRM2—Metabolism—TH—peripheral nervous system neoplasm	0.000116	0.00151	CbGpPWpGaD
Clofarabine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00032	CcSEcCtD
Clofarabine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000319	CcSEcCtD
Clofarabine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000115	0.000318	CcSEcCtD
Clofarabine—DCK—Metabolism—BCHE—peripheral nervous system neoplasm	0.000115	0.00151	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000115	0.0015	CbGpPWpGaD
Clofarabine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000314	CcSEcCtD
Clofarabine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000312	CcSEcCtD
Clofarabine—RRM1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000112	0.00147	CbGpPWpGaD
Clofarabine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000311	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000311	CcSEcCtD
Clofarabine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000112	0.00031	CcSEcCtD
Clofarabine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000309	CcSEcCtD
Clofarabine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000309	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000309	CcSEcCtD
Clofarabine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000111	0.000308	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000111	0.00145	CbGpPWpGaD
Clofarabine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000305	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000305	CcSEcCtD
Clofarabine—DCK—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00011	0.00144	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TH—peripheral nervous system neoplasm	0.000108	0.00142	CbGpPWpGaD
Clofarabine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000299	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000298	CcSEcCtD
Clofarabine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000107	0.000298	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000297	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000296	CcSEcCtD
Clofarabine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000295	CcSEcCtD
Clofarabine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000292	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00029	CcSEcCtD
Clofarabine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000288	CcSEcCtD
Clofarabine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000103	0.000286	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000286	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000286	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000286	CcSEcCtD
Clofarabine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000284	CcSEcCtD
Clofarabine—Rash—Etoposide—peripheral nervous system neoplasm	0.000102	0.000284	CcSEcCtD
Clofarabine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000102	0.000284	CcSEcCtD
Clofarabine—Headache—Etoposide—peripheral nervous system neoplasm	0.000102	0.000282	CcSEcCtD
Clofarabine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	9.98e-05	0.000277	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000277	CcSEcCtD
Clofarabine—Cough—Epirubicin—peripheral nervous system neoplasm	9.73e-05	0.00027	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	9.65e-05	0.00126	CbGpPWpGaD
Clofarabine—Nausea—Etoposide—peripheral nervous system neoplasm	9.65e-05	0.000267	CcSEcCtD
Clofarabine—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.000267	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	9.56e-05	0.00125	CbGpPWpGaD
Clofarabine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000264	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000263	CcSEcCtD
Clofarabine—Myalgia—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000263	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000263	CcSEcCtD
Clofarabine—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.000262	CcSEcCtD
Clofarabine—RRM2—Metabolism—GNAS—peripheral nervous system neoplasm	9.44e-05	0.00124	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.43e-05	0.000261	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.37e-05	0.00123	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.36e-05	0.00123	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.26e-05	0.00121	CbGpPWpGaD
Clofarabine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.24e-05	0.000256	CcSEcCtD
Clofarabine—Oedema—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000252	CcSEcCtD
Clofarabine—Infection—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000251	CcSEcCtD
Clofarabine—Cough—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.00025	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	8.98e-05	0.00118	CbGpPWpGaD
Clofarabine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.000247	CcSEcCtD
Clofarabine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000247	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000247	CcSEcCtD
Clofarabine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000246	CcSEcCtD
Clofarabine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	8.84e-05	0.000245	CcSEcCtD
Clofarabine—DCK—Metabolism—GNAS—peripheral nervous system neoplasm	8.82e-05	0.00116	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000244	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000244	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000244	CcSEcCtD
Clofarabine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000243	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	8.73e-05	0.000242	CcSEcCtD
Clofarabine—Anorexia—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.00024	CcSEcCtD
Clofarabine—DCK—Metabolism—ABCB1—peripheral nervous system neoplasm	8.65e-05	0.00113	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	8.63e-05	0.00113	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	8.61e-05	0.00113	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—peripheral nervous system neoplasm	8.55e-05	0.00112	CbGpPWpGaD
Clofarabine—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000236	CcSEcCtD
Clofarabine—Oedema—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000233	CcSEcCtD
Clofarabine—Infection—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000232	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.00023	CcSEcCtD
Clofarabine—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	8.29e-05	0.00109	CbGpPWpGaD
Clofarabine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000229	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.000229	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.22e-05	0.000228	CcSEcCtD
Clofarabine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000227	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000227	CcSEcCtD
Clofarabine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000226	CcSEcCtD
Clofarabine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.000225	CcSEcCtD
Clofarabine—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000224	CcSEcCtD
Clofarabine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000223	CcSEcCtD
Clofarabine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000219	CcSEcCtD
Clofarabine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000218	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	7.86e-05	0.000218	CcSEcCtD
Clofarabine—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.000218	CcSEcCtD
Clofarabine—Pain—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000216	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000213	CcSEcCtD
Clofarabine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.00021	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.53e-05	0.000987	CbGpPWpGaD
Clofarabine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000208	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.5e-05	0.000208	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000208	CcSEcCtD
Clofarabine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000206	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.39e-05	0.000969	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000203	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000202	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.26e-05	0.000201	CcSEcCtD
Clofarabine—Pain—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.0002	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000199	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000199	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TP53—peripheral nervous system neoplasm	7.02e-05	0.00092	CbGpPWpGaD
Clofarabine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.000192	CcSEcCtD
Clofarabine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000191	CcSEcCtD
Clofarabine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000186	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000185	CcSEcCtD
Clofarabine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000185	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	6.54e-05	0.000857	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000181	CcSEcCtD
Clofarabine—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000178	CcSEcCtD
Clofarabine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000173	CcSEcCtD
Clofarabine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000172	CcSEcCtD
Clofarabine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000167	CcSEcCtD
Clofarabine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.02e-05	0.000167	CcSEcCtD
Clofarabine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000165	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—MYC—peripheral nervous system neoplasm	5.85e-05	0.000766	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.00016	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.00016	CcSEcCtD
Clofarabine—Rash—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000159	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.73e-05	0.000159	CcSEcCtD
Clofarabine—Headache—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000158	CcSEcCtD
Clofarabine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	0.000154	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	5.44e-05	0.000713	CbGpPWpGaD
Clofarabine—Nausea—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.00015	CcSEcCtD
Clofarabine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000148	CcSEcCtD
Clofarabine—Rash—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000147	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000147	CcSEcCtD
Clofarabine—Headache—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000146	CcSEcCtD
Clofarabine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000139	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—TP53—peripheral nervous system neoplasm	4.8e-05	0.000629	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	4.6e-05	0.000602	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.39e-05	0.000575	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	4.32e-05	0.000566	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	3.53e-05	0.000462	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.46e-05	0.000454	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—peripheral nervous system neoplasm	3.09e-05	0.000405	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—peripheral nervous system neoplasm	2.55e-05	0.000334	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—peripheral nervous system neoplasm	2.38e-05	0.000312	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	9.52e-06	0.000125	CbGpPWpGaD
